KRONOS ADVANCED TECHS INC - KNOS STOCK NEWS

Kronos Advanced Technologies Inc. (OTC: KNOS) has issued a warning to consumers, urging them to use only FDA-cleared air purifiers at home and in offices. This advisory comes amid growing concerns about the safety and effectiveness of non-FDA-cleared air purification products. KNOS, a leading innovator in air purification technology, emphasizes the importance of verifying FDA clearance status for air purifiers to ensure a healthy indoor environment.

The company offers a range of FDA-cleared air purifiers, including the popular Model 5 and Model 8, which use patented Kronos® CORE air disinfection technology. These devices can remove contaminants down to 14.6 nanometers, 20 times smaller than HEPA filters. The Model 5, suitable for rooms up to 1400 sq. ft., is currently on sale for $549, while the Model 8, ideal for spaces up to 3000 sq. ft., is priced at $949.

Kronos Advanced Technologies announced that its Model 8 air purifier has received FDA 510(k) clearance as a Class II Medical Device, following the clearance of its Model 5 in 2023. The Model 8 uses patented Kronos® CORE technology to eliminate 99.9% of harmful airborne particles, including viruses like COVID-19. This clearance allows deployment in healthcare settings, homes, schools, and businesses. The global air purifier market is projected to grow from $15.94 billion in 2023 to $25.58 billion by 2030. Kronos' purifiers have a significant market advantage, removing particles 20 times smaller than HEPA filters. Prices for the Model 5 and Model 8 are currently $549 and $949, respectively.

Kronos Advanced Technologies (OTC: KNOS) has announced the acceptance of Shiba Inu (SHIB) cryptocurrency as a payment method for their air purifiers, making them the first public company to embrace SHIB. This move aims to provide a seamless and secure transaction experience for customers, reflecting the company's commitment to technological advancements and customer satisfaction. As of 2024, there are approximately 1.38 million SHIB wallet holders. Kronos is offering a 10% discount for a time to customers who choose to pay with SHIB, enhancing value and experience. CEO Greg Rubin expressed excitement about this partnership, which is expected to solidify Kronos' position as a leader in the air purification industry.

KronosMD, a subsidiary of Kronos Advanced Technologies (OTC: KNOS), announced the filing of a provisional patent application for an innovative teeth whitening technology utilizing ultrasound. This non-invasive method aims to enhance the teeth whitening process by safely penetrating enamel and dentin to remove stains without damaging teeth or gums. The global teeth whitening market is projected to reach $6.9 billion with a growth rate of 6.7% from 2021 to 2028, indicating significant market potential for KronosMD's technology. The company plans to protect its intellectual property while expanding its portfolio, which includes over 20 provisional patents and granted patents in dental imaging and ultrasound products.

Kronos Advanced Technologies (KNOS) announced the integration of ChatGPT into its Shopify-powered online store on March 29, 2023. This AI enhancement aims to revolutionize the e-commerce customer experience by offering personalized shopping assistance, 24/7 customer support, and improved engagement through interactive conversations. The integration is expected to raise conversion rates by guiding customers through purchases and providing product-related information. Moreover, ChatGPT can handle multiple customer queries at once, allowing Kronos to scale its operations efficiently, while also delivering data analytics to refine marketing and product strategies.

KronosMD, a subsidiary of Kronos Advanced Technologies (OTC MARKETS: KNOS), announced the filing of a provisional patent application for a unique remote digital dental imaging technology. This innovation aims to enhance the quality of 3D dental arch scans, targeting the growing Direct-to-Consumer orthodontic aligner market, projected to reach USD 10.04 billion by 2028 with a CAGR of 19.7%. KronosMD's technology could streamline manufacturing processes while generating cost savings and expediting treatment monitoring. The company is committed to expanding its intellectual property portfolio, including over 20 provisional patents in dental ultrasound imaging.

KronosMD, a subsidiary of Kronos Advanced Technologies (OTC: KNOS), has acquired all assets and intellectual property related to its innovative 3D ultrasound dental imaging devices. This acquisition aims to boost the commercialization of the S-WAVE™ platform, which is nearing completion. The 3D ultrasound-powered S-WAVE SCAN™ is positioned to transform dental imaging by providing radiation-free diagnostics, enhancing safety and accuracy for patients. With a projected ultrasound devices market size of $9.1 billion by 2027, the strategic importance of this acquisition is evident as it positions KronosMD to lead in a rapidly evolving market.

KronosMD (OTC: KNOS) announced that CEO Dr. Greg Rubin will attend the Roth Investor Conference on March 13-14, 2023, to engage with investors, investment bankers, and industry leaders. Attendees can schedule meetings with Dr. Rubin to discuss capital provisions and learn about KronosMD's innovative digital health technology, including the transformative SWAVE™ ultrasound imaging for dental care. This conference is a significant platform for small-cap companies, offering networking and insights into investment opportunities across various sectors.

Investors seeking further details can reach out via KronosMD's investor relations.